The biotech will first tackle lysosomal storage disorders

CAR T-cell therapy works wonders for some cancer patients. For others, it is a death sentence. To make the revolutionary therapy work for more people, scientists must devise better ways to control it

The drug company will pay $1.6 billion to gain Armo’s IL-10 program

Joined by CRISPR luminaries Feng Zhang and J. Keith Joung, the Harvard chemist raises up to $87 million in funding

The start-up, based on the work of Broad Institute scientist Aviv Regev, has raised $65 million to develop therapies for cancer and autoimmune disease

El triclorofluorometano probablemente se origine en fábricas del este de Asia

With $40 million series A funding, the start-up will develop inhibitors of proteins that make chemical modifications to RNA

Updated following the West, Texas, fertilizer explosion, rule is intended to prevent incidents at facilities handling large amounts of hazardous materials

Joined by CRISPR luminaries Feng Zhang and J. Keith Joung, the Harvard chemist raises up to $87 million in funding

Company expects to slim its home country head count by 600

Updated following the West, Texas, fertilizer explosion, rule is intended to prevent incidents at facilities handling large amounts of hazardous materials

A new report from the Cancer Research Institute highlights the U.S. and China as cell therapy leaders

With so many ingredients on hand, can the oncology community figure out how to sensibly and efficiently combine checkpoint inhibitors with other drugs?

The startup is developing allosteric activators to increase levels of the vital metabolic molecule coenzyme A in pantothenate kinase-associated neurodegeneration

The early peek at data from a Phase I/II study excited families, physicians, and investors 

Food regulation, graduate education among changes put forward

Additive facilitates numerous pharmaceutically relevant reactions through unknown mechanism

Piramal sites on different continents have become involved in producing Theracos’s diabetes treatment

The drug company is partnering with Calibr to develop universal CAR T-cells directed to different tumors via antibody switches

Skyhawk will receive $60 million up front to develop drug candidates that target RNA in neurological diseases

The drug company is partnering with Calibr to develop universal CAR T cells directed to different tumors via antibody switches

Improvements to device may eventually cut external power demands for buildings by 50%

Textured catalyst prevents gas bubbles from clinging to surfaces

PlantArcBio, an Israeli start-up, will try out its new soybean genes at the University of Wisconsin

Researchers are working to fix genetic conditions like Gaucher disease before birth by testing experimental therapies on fetal animals

The company claims its technology will allow it to access previously undruggable targets

Cation gets a conductivity boost by capturing its counterion

The company claims its technology will allow it to access previously undruggable targets

Echo Buds are available at ₹11,999 for the USB-C wired charging option, and at ₹13,999 for wireless charging case option

Packed with technology, the camera probably ticks all the boxes for the professional photographer

Sony Venice 2 cameras come with two kinds of sensors

The joint venture company will acquire, develop, and maintain the MF Central platform, which serves as an execution-only platform for mutual fund transactions

The State-owned insurer recorded 12 per cent growth in net premium income at ₹1,19,901 crore during the quarter under review